# Dario D. Altamirano, DO – FDA Inspection, Feb 9, 2022

Source: https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/0ffb1049-ef28-40c3-bad7-75a117488dca
Source feed: FDA_Inspections

> FDA inspection 1161913 of Dario D. Altamirano, DO, February 09, 2022. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161913
- Company Name: Dario D. Altamirano, DO
- Inspection Date: 2022-02-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1279838 - 2025-08-21
- [FDA Inspection 1066302 - 2018-09-21](https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/49ae984b-e792-4681-af3d-2e79ffefe8df)
- FDA Inspection 838564 - 2013-06-28
- [FDA Inspection 754975 - 2011-11-03](https://www.keypedia.com/records/fda_inspections/dario-d-altamirano-do/5f30fdc9-ff94-42e3-8a63-038c999f77ca)

Company: https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c